Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical

David Suster1, Michael Michal2,3,4, Michiya Nishino1

  • 1Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Related Concept Videos